# Glutamate enhances the production of inflammatory cytokines IL-6 and IL-11, as well as chemokines CXCL2, CXCL3, and CXCL8 in keloid fibroblasts

**Authors:** Yan Chen, Yaohan Xu, Jiahe Zhang, Chenxi Feng, Jie Chen, Yinjing Song, Jing Pan, Jiang Zhu, Hao Cheng

PMC · DOI: 10.3389/fmolb.2025.1720876 · Frontiers in Molecular Biosciences · 2026-01-05

## TL;DR

This study shows that glutamate boosts inflammation in keloid fibroblasts, suggesting it plays a key role in keloid development and could be a target for treatment.

## Contribution

The study identifies glutamate's role in enhancing inflammatory responses in keloid fibroblasts through experimental validation.

## Key findings

- Keloid tissues show increased glutamate and glutamine levels and upregulated GRIN2D in fibroblasts.
- Glutamate stimulation increases IL-6, IL-11, CXCL2, CXCL3, and CXCL8 production in fibroblasts.
- Glutamate metabolism contributes to inflammatory functions in keloid progression.

## Abstract

Keloids are fibroproliferative skin scars characterized by excessive extracellular matrix deposition and a high rate of recurrence. Despite extensive research, their pathogenesis remains incompletely understood and effective curative therapies are lacking.

RNA sequencing (RNA-seq) and metabolomics were performed to compare gene expression and metabolite profiles between human keloid tissues and normal skin. Single-cell RNA sequencing, immunohistochemistry, and immunofluorescence were used to determine the cellular localization of key genes. In vitro, human fibroblasts were stimulated with glutamate, followed by RNA-seq, quantitative RT-PCR, and ELISA to evaluate inflammatory gene expression and cytokine secretion.

Transcriptomic analysis revealed significant enrichment of the neuroactive ligand-receptor interaction pathway in keloid tissue, with marked upregulation of the glutamate receptor subunit GRIN2D. Single-cell and histological analyses demonstrated that GRIN2D is predominantly expressed in fibroblasts. Metabolomic profiling showed significantly increased levels of glutamate and glutamine in keloid tissues. Glutamate stimulation of fibroblasts significantly enhanced the expression and secretion of inflammatory cytokines IL-6 and IL-11, as well as chemokines CXCL2, CXCL3, and CXCL8 (IL-8).

These results underscore the crucial role of glutamate metabolism in promoting the infammatory functions of fbroblasts. They suggest that glutamate contributes to keloid progression and provides a theoretical basis for targeting glutamte signaling pathway in keloid treatment.

## Linked entities

- **Genes:** GRIN2D (glutamate ionotropic receptor NMDA type subunit 2D) [NCBI Gene 2906]
- **Chemicals:** glutamate (PubChem CID 611), glutamine (PubChem CID 738)

## Full-text entities

- **Genes:** CXCL3 (C-X-C motif chemokine ligand 3) [NCBI Gene 2921] {aka CINC-2b, GRO3, GROg, MIP-2b, MIP2B, SCYB3}, IL11 (interleukin 11) [NCBI Gene 3589] {aka AGIF, IL-11}, GRIN2D (glutamate ionotropic receptor NMDA type subunit 2D) [NCBI Gene 2906] {aka DEE46, EB11, EIEE46, GluN2D, NMDAR2D, NR2D}, CXCL2 (C-X-C motif chemokine ligand 2) [NCBI Gene 2920] {aka CINC-2a, GRO2, GROb, MGSA-b, MIP-2a, MIP2}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, CXCL8 (C-X-C motif chemokine ligand 8) [NCBI Gene 3576] {aka GCP-1, GCP1, IL8, LECT, LUCT, LYNAP}
- **Diseases:** Keloids (MESH:D007627), inflammatory (MESH:D007249)
- **Chemicals:** Glutamate (MESH:D018698), glutamte (-), glutamine (MESH:D005973)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12812582/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12812582/full.md

## References

48 references — full list in the complete paper: https://tomesphere.com/paper/PMC12812582/full.md

---
Source: https://tomesphere.com/paper/PMC12812582